TP73 and glioblastoma: Follow-up of patients with GBM showed that overexpression of TP73-AS1, a GBM-associated lncRNA, maintains stemness of GSCs through interactions involving multiple pathways, thus leading to increased resistance of GBM cells to TMZ therapy (4).